Wikidata

(Q53415608)

English

Bortezomib (Velcade), rituximab, cyclophosphamide, and dexamethasone combination regimen is active as front-line therapy of low-grade non-Hodgkin lymphoma.

scientific article published on 14 July 2011

In more languages
default for all languages
No label defined

No description defined

Statements

title
Bortezomib (Velcade), rituximab, cyclophosphamide, and dexamethasone combination regimen is active as front-line therapy of low-grade non-Hodgkin lymphoma. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21752745
retrieved
14 May 2018
reference URL
http://europepmc.org/abstract/MED/21752745

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q53415608&oldid=1561117096"